LAS VEGAS, Aug. 21, 2014 (GLOBE NEWSWIRE) -- GrowBLOX Sciences, Inc. (OTCQB:GBLX), a medical marijuana research and development company, announced that CEO Craig Ellins will be presenting on the Medical Marijuana Stocks Public Company Panel at The Money Show on August 22, 2014, from 10:30am-11:30am PDT at the Hilton San Francisco Union Square. Mr. Ellins will be joined by 50+ other top industry service and product providers to discuss the emerging medical marijuana industry. The Company invites its shareholders and other interested parties to tune in and view the panel discussion live by registering for free at: http://www.moneyshow.com/eshow/san_francisco/moneyshow/main.asp?scode=035226
The Company will also be presenting its business, science, and technology in the general exhibit hall.
About The Money Show
Guided by the belief that "knowledge is power" and recognizing the desire of independent minds to rely on self rather than institution, MoneyShow has been empowering individuals with a passion for investing for three decades. The company pioneered the investment tradeshow field in the early 80s, creating the concept of a "MoneyShow" and developing a business model which gathers qualified investors, traders, and financial advisors together with top financial experts, business, and media professionals, offering all participants unparalleled opportunities for profitable interactivity, idea exchange, relationship-building, and learning. MoneyShow has evolved into a global, financial media company known as the world's leading producer of investment and trading tradeshows, as well as producer of the award-winning, multimedia online community, MoneyShow.com, and the interactive eShows.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Jonathan Barkman Riverview Capital Enterprises +1-866-845-0105Source:GrowBlox Sciences Inc